Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
CA 2356595 A1 · Owner: Sakai, Harumi · Inventors: Sakai, Harumi; Ikeda, Joh-E
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monoclonal antibodies specifically recognizing a human apoptosis inhibitory protein NAIP having the amino acid sequence represented by SEQ ID NO:1 which are anti-NAIP monoclonal antibodies produced respectively by hybridomas prepared by fusing antibody-producing cells of mammals immunized with immunogens containing a polypeptide comprising the amino acid sequence consisting of the amino acids of the numbers 256 to 586 in SEQ ID NO:1 or a polypeptide comprising the amino acid sequence consisting of the amino acids of the numbers 841 to 1052 in SEQ ID NO:1 or parts thereof with a myeloma cell line; a method for assaying NAIP by using these antibodies; and NAIP assay kits.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.